Ovarian cancer

Ovarian cancer screening

✍ J. R. van Nagell Jr 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

During the past two decades, there have been a number of significant advances in the evaluation and treatment of ovarian cancer. These include documentation of the importance of thorough surgical staging, confirmation of the prognostic effect of aggressive tumor debulking, and demonstration of the e

Endocrine ovarian-cancer relationships

✍ Arthur T. Hertig 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

Retinoids and ovarian cancer

✍ Dongmei Zhang; William F. Holmes; Shujian Wu; Dianne R. Soprano; Kenneth J. Sopr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

Each year, an estimated 26,000 women in the United States are diagnosed with ovarian cancer. During any given year, approximately 14,500 women die from this disease. Ovarian cancer is the seventh most common cancer in women worldwide, after breast, cervix, colon/rectum, stomach, corpus uteri, and lu

Guest editorial:Ovarian cancer—1996

✍ Averette, Hervy E. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

Surgical management of ovarian cancer

✍ Thomas C. Randall; Stephen C. Rubin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

Ovarian cancer affects over 25,000 women each year in the United States. The performance of appropriate surgery for ovarian cancer is critical in directing further therapies and improving survival. Systematic surgical staging must be performed in patients who appear to have early stage ovarian cance

Managing hereditary ovarian cancer risk

✍ Andrew Berchuck; Joellen M. Schildkraut; Jeffrey R. Marks; P. Andrew Futreal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Ovarian cancer is the fourth leading cause of cancer deaths in American women. About 10% of cases are thought to have a hereditary basis, and family history is the strongest known risk factor. In the past, prophylactic oophorectomy has been advocated for women with two or more affected first-degree